Eloxx Pharmaceuticals, Inc. (199) | Uncategorized (42)
Recent Contracts
-
Description of Registered Securities
(Filed With SEC on March 30, 2022)
-
Offer to Gregory Weaver from Eloxx Pharmaceuticals Ltd., dated September 11, 2017
(Filed With SEC on December 22, 2017)
-
Offer to Pedro Huertas from Eloxx Pharmaceuticals Ltd., dated April 17, 2015
(Filed With SEC on December 22, 2017)
-
Amendment to Agreement, dated as of November 23, 2017, by and among Sevion Therapeutics, Inc., Sevion Sub, Ltd. and Eloxx Pharmaceuticals Ltd
(Filed With SEC on November 29, 2017)
-
Amendment to Agreement, dated as of August 1, 2017, by and among Sevion Therapeutics, Inc., Sevion Sub, Ltd. and Eloxx Pharmaceuticals Ltd
(Filed With SEC on October 13, 2017)
-
SUBSCRIPTIONAGREEMENT
(Filed With SEC on August 3, 2017)
-
AGREEMENT
(Filed With SEC on June 6, 2017)
-
SEVIONTHERAPEUTICS, Inc. AMENDMENTTO ConsultingAgreement
(Filed With SEC on May 12, 2016)
-
SUBSCRIPTIONAGREEMENT
(Filed With SEC on October 9, 2015)
-
SEVIONTHERAPEUTICS, Inc. ConsultingAgreement
(Filed With SEC on May 14, 2015)
-
SEVIONTHERAPEUTICS, Inc. ConsultingAgreement
(Filed With SEC on February 17, 2015)
-
REVISEDBUDGET YEAR16 PERIOD:March 1, 2014 – August 31, 2014
(Filed With SEC on May 9, 2014)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on December 12, 2013)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on December 6, 2013)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on October 1, 2013)
-
Senesco Technologies, Inc. 721 Route 202/206 | Suite 130 | Bridgewater, NJ 08807 p 908 864 4444 | f 908 864 4440 www.senesco.com
(Filed With SEC on September 11, 2013)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on May 9, 2013)
-
Chardan Capital Markets, LLC 17 State Street, Suite 1600 New York, New York 10004
(Filed With SEC on May 9, 2013)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on January 4, 2013)
-
AMENDMENT TO RESEARCHAGREEMENT
(Filed With SEC on September 28, 2012)
-
SENESCOTECHNOLOGIES, INC. INDEMNIFICATIONAGREEMENT
(Filed With SEC on May 25, 2010)
-
Nondisclosure,Noncompetition and InventionAssignment Agreement
(Filed With SEC on May 25, 2010)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on March 29, 2010)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on March 29, 2010)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on March 29, 2010)
-
[End of text.]
(Filed With SEC on March 5, 2010)
-
SENESCOTECHNOLOGIES, INC. RESTRICTEDSTOCK UNIT ISSUANCE AGREEMENT
(Filed With SEC on November 16, 2009)
-
SENESCOTECHNOLOGIES, INC. INDEMNIFICATIONAGREEMENT
(Filed With SEC on September 28, 2009)
-
SENESCOTECHNOLOGIES, INC. INDEMNIFICATIONAGREEMENT
(Filed With SEC on September 28, 2009)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on July 30, 2009)
-
EXHIBIT10.2 SECURITIESPURCHASE AGREEMENT
(Filed With SEC on July 30, 2009)
-
SECURITIESPURCHASE AGREEMENT
(Filed With SEC on July 10, 2009)
-
SENESCO TECHNOLOGIES, INC. 2008 INCENTIVECOMPENSATION PLAN
(Filed With SEC on February 17, 2009)
-
Proposal for Biodistribution and Repeat DoseToxicity Studies in Mice Submitted by: BioReliance 14920 Broschart Road Rockville, MD 20850 To: Cato Research Ltd. and Senesco...
(Filed With SEC on November 14, 2008)
-
Confidential Treatment Requested under 17C.F.R. 200.80(b)(4) and240.24b-2
(Filed With SEC on September 26, 2008)
-
LICENSEAGREEMENT between BAYER CROPSCIENCE AG and SENESCOTECHNOLOGIES, INC.
(Filed With SEC on November 14, 2007)
-
SENESCOTECHNOLOGIES, INC. INDEMNIFICATIONAGREEMENT
(Filed With SEC on September 28, 2007)
-
[INSERT H.C.WAINWRIGHT LETTERHEAD]
(Filed With SEC on September 28, 2007)
-
STANFORD GROUPCOMPANY
(Filed With SEC on October 13, 2006)
-
H. C .WAINWRIGHT &CO., lNC. Investments Since 1868
(Filed With SEC on October 13, 2006)